Get it on Google Play

Sorrento Therapeutics (SRNE) majority-owned subsidiary Scilex receives FDA approval for Ztildo

April 9, 2021 10:00 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Sorrento Therapeutics (NASDAQ: SRNE) majority-owned subsidiary Scilex receives FDA approval for Ztildo.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA

Related Entities

FDA